Herpes-Zoster Vaccine: Impact on Patients with Inflammatory Rheumatic Diseases

We are studying how anti-rheumatic treatments influence the effectiveness of the herpes-zoster vaccine in patients with inflammatory rheumatic diseases. This research aims to see if the vaccine provides adequate protection against shingles.

Monitoring phase (IV)Infectious DiseasesRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Region Skane Skanes Universitetssjukhus
SUS, reumatologi >LUnd/Malmö
Lund, Sweden
Sponsor: Region Skane Skanes Universitetssjukhus
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.